Emendo Biotherapeutics vs Ultragenyx
Emendo Biotherapeutics vs Ultragenyx, compared side by side on 20 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Emendo Biotherapeutics is on 59/100 and Ultragenyx on 55/100.
Where each one leads
Emendo Biotherapeutics
- our overall score: 59/100 against 55/100
Ultragenyx
- agent readiness: 50/100 against 40/100
- domain rating: 67/100 against 20/100
- headcount: 1,498 against 41
- funding raised: $100M against $61.0M
- LinkedIn following: 113,428 against 5,333
At a glance
| Measure | Emendo Biotherapeutics | Ultragenyx |
|---|---|---|
| What it is | Developing genetic medicines and cell therapies for severe diseases using proprietary CRISPR OMNI technology. | Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases. |
| Category | Healthcare, Genome Editing, CRISPR, Biotech | Biotech, MedTech, HealthTech, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | 2015 | 2010 |
| Headquarters | Tel Aviv, Israel | Novato, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Emendo Biotherapeutics | Ultragenyx |
|---|---|---|
| Employees | 41 | 1,498 |
| Headcount growthLast 12 months | -16.1% | Not published |
| Total funding | $61.0M | $100M |
| Latest round | Series B | IPO |
| LinkedIn followers | 5,333 | 113,428 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Emendo Biotherapeutics | Ultragenyx |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 59/100 | 55/100 |
| Traction | 55/100 | 60/100 |
| Team | 40/100 | 20/100 |
| Search visibility | 44/100 | 25/100 |
| Quality | 68/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (40/100) | D (50/100) |
| Domain ratingLink authority, 0-100 | 20/100 | 67/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Emendo Biotherapeutics | Ultragenyx |
|---|---|---|
| Hosting | Google Cloud | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | WordPress | Not detected |
| Frameworks | Bootstrap | Tailwind CSS |
| Analytics | Google Tag Manager | Not detected |
| Open source | No | Yes |
Emendo Biotherapeutics vs Ultragenyx: common questions
Which is better, Emendo Biotherapeutics or Ultragenyx?
On our 0-100 score Emendo Biotherapeutics rates higher (59/100 against 55/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 20 data points above: read the rows that match what you are buying for.
How do Emendo Biotherapeutics and Ultragenyx compare on the numbers?
Emendo Biotherapeutics leads on our overall score (59/100 against 55/100). Ultragenyx leads on agent readiness (50/100 against 40/100), domain rating (67/100 against 20/100), headcount (1,498 against 41), funding raised ($100M against $61.0M), LinkedIn following (113,428 against 5,333).
Read the full Emendo Biotherapeutics review and pricing or the Ultragenyx review and pricing. You can also browse other Emendo Biotherapeutics alternatives we track.